LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
Alphabet Inc. Class C (GOOGL.US) CEO warning: There are irrational factors in the current AI market. If the bubble bursts, no company will be spared.
LIANLIAN (02598) spent approximately 9.9976 million Hong Kong dollars to repurchase 1.3325 million shares on November 18th.
Fengshi Corporation's IPO on the Shanghai Stock Exchange was approved. The company is a professional manufacturer of materials for wind turbine blades.
Alphabet Inc. Class C (GOOGL.US) CEO warning: There are irrational factors in the current AI market. If the bubble bursts, no company will be spared.
LIANLIAN (02598) spent approximately 9.9976 million Hong Kong dollars to repurchase 1.3325 million shares on November 18th.
Fengshi Corporation's IPO on the Shanghai Stock Exchange was approved. The company is a professional manufacturer of materials for wind turbine blades.
RECOMMEND
U.S. equities face “key defense lines,” testing bullish conviction; a break would confirm a downtrend into “early next year”
17/11/2025
Year-to-date Hong Kong share buybacks surpass HK$140 billion, with technology and financials leading activity
17/11/2025
Bitcoin’s year-to-date 30% rally “fully erased,” market slips into a bear phase
17/11/2025
